Predict your next investment

Solace Therapeutics company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
solacetx.com

See what CB Insights has to offer

Stage

Loan | Alive

Total Raised

$31.68M

Last Raised

$250K | 2 yrs ago

About Solace Therapeutics

Solace Therapeutics is a medical device company focused on the development of non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). Solace is dedicated to improving the patient's quality of life by eliminating side effects typically associated with current drug and surgical therapies.

Solace Therapeutics Headquarter Location

135 Newbury Street

Framingham, Massachusetts, 01701,

United States

508-283-1200

Latest Solace Therapeutics News

Solace Therapeutics Announces that Dr. Cindy Basinski and Team at CMB Research Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)

Apr 21, 2021

Download April 21, 2021 09:00 AM Eastern Daylight Time NEWBURGH, Ind.--( BUSINESS WIRE )--Dr. Cindy Basinski and Team at CMB Research, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. “I am delighted to be participating in the VESAIR Clinical Study. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman’s Quality of Life. Having a non-surgical option would be a great alternative for the nearly 1 in 2 women over the age of 50, who suffer from this condition,” said Cindy Basinski, MD, Principal Investigator for the VESAIR Clinical Study. About Stress Urinary Incontinence and the Vesair Bladder Control System Women with Stress Urinary Incontinence (SUI) typically experience sudden increases in bladder pressure during physical movement, for example coughing, laughing, sneezing, or during exercise. When this increased bladder pressure exceeds the ability of the urethral sphincter to withstand pressure, leakage occurs. Unlike currently available SUI treatments that focus on improving the urethral closure force, the Vesair Bladder Control System is designed to reduce rapid increases in bladder pressure through the placement of a compressible air-filled balloon in the bladder. The balloon acts like a “shock-absorber” to slow rapid changes in pressure and reduce leakage. The uninflated balloon is placed into the bladder through the urethra and subsequently inflated. Balloon placement is performed during an in-office procedure that does not require anesthesia. When necessary, the balloon is deflated and removed in a similar in-office procedure. Most women manage their SUI with absorbent pads and are reluctant to undergo surgery for a variety of reasons. To learn more about the VESAIR Clinical Trial visit; www.vesairstudy.com . About Solace Therapeutics, Inc. Solace Therapeutics is an emerging women’s health company focused on a new office-based treatment for symptoms of female SUI. SUI is the most prevalent form of incontinence among women and affects an estimated 15 million adult women in the U.S. These women choose to manage their SUI by utilizing absorbent products such as protective pads versus seeking medical help. Solace is dedicated to improving the quality of life for women whose daily life is disrupted by their incontinence. Please visit www.solacetx.com to learn more about the company and review results from the first two clinical trials. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Solace Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Solace Therapeutics is included in 2 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

960 items

Startups focused on providing products and services catering to women's health and wellbeing.

M

Medical Devices

10,972 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Solace Therapeutics Patents

Solace Therapeutics has filed 12 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Digestive system surgery
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/10/2018

10/13/2020

Medical equipment, Mammal male reproductive system, Urology, Urinary system, Penis

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/10/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/13/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Medical equipment, Mammal male reproductive system, Urology, Urinary system, Penis

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Solace Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Solace Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.